Chia-Fone Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chia-Fone Lee has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Yu-Lin Song
Department of Computer Science and Information Engineering, Asia University, Taichung, Taiwan
3 shared publications Bo-Cheng Chen
Department of Otolaryngology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
2 shared publicationsLian-Jie Lin
Department of Otolaryngology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
2 shared publicationsYi-Chen Lin
Department of Otolaryngology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan
2 shared publications- Cheng-Hsiang Cheng
Department of Electronics Engineering and the Institute of Electronics, National Chiao Tung University, 34914 Hsinchu Taiwan
1 shared publication - Chia-Hsiang Yang
National Taiwan University
1 shared publication
Latest Publications
- 9 January 2025
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 46 (3) , 321-329
Auditory Brainstem Response (ABR) Recording of Simultaneous Electric–Acoustic Stimulation between Round Window Membrane and Basal Part of Cochlear Bone in guinea Pigs
Hypothesis: Extracochlear electric–acoustic stimulation (EAS) between the round window membrane and the basal part of the cochlear bone exhibits distinct auditory brainstem response (ABR) characteristics. Background: The use of EAS in individuals with residual hearing is becoming increasingly common in clinical settings. Ongoing research has explored the characteristics of EAS-induced responses in hearing cochleae. Methods: This study explored a novel extracochlear EAS approach using round window membrane–cochlear bone stimulation to maintain cochlear integrity. The electrodes stimulate the basal part of the cochlea and spare the apex, making the model ideal for EAS candidates with profound high-frequency hearing loss and residual low-frequency hearing. ABR analyses of EAS were conducted to compare responses to acoustic, electrical, and combined stimulations. Results: The threshold of EAS was higher than that of acoustic stimulation (AS) or electric stimulation (ES). The maximum peak height of the amplitude (MPHA) in the EAS showed sound pressure level (SPL)- and electric current-dependent changes, with superior performance at higher SPLs. The MPHA latency shift index analysis demonstrated significant differences between the EAS and the AS or ES only. In the context of EAS, neural responses occurring before 4 ms are defined as early responses, which are related to the stimulus. Late responses, occurring after 4 ms, suggest distinct physiological mechanisms that may involve synaptic actions or specific interactions within the EAS. Conclusion: Extracochlear EAS provides insights into its physiological implications, proposes a method for clinical application, and offers a potential avenue for improving hearing preservation and performance.
- 9 January 2025
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 46 (3) , 321-329
Auditory Brainstem Response (ABR) Recording of Simultaneous Electric–Acoustic Stimulation between Round Window Membrane and Basal Part of Cochlear Bone in guinea Pigs
Hypothesis: Extracochlear electric–acoustic stimulation (EAS) between the round window membrane and the basal part of the cochlear bone exhibits distinct auditory brainstem response (ABR) characteristics. Background: The use of EAS in individuals with residual hearing is becoming increasingly common in clinical settings. Ongoing research has explored the characteristics of EAS-induced responses in hearing cochleae. Methods: This study explored a novel extracochlear EAS approach using round window membrane–cochlear bone stimulation to maintain cochlear integrity. The electrodes stimulate the basal part of the cochlea and spare the apex, making the model ideal for EAS candidates with profound high-frequency hearing loss and residual low-frequency hearing. ABR analyses of EAS were conducted to compare responses to acoustic, electrical, and combined stimulations. Results: The threshold of EAS was higher than that of acoustic stimulation (AS) or electric stimulation (ES). The maximum peak height of the amplitude (MPHA) in the EAS showed sound pressure level (SPL)- and electric current-dependent changes, with superior performance at higher SPLs. The MPHA latency shift index analysis demonstrated significant differences between the EAS and the AS or ES only. In the context of EAS, neural responses occurring before 4 ms are defined as early responses, which are related to the stimulus. Late responses, occurring after 4 ms, suggest distinct physiological mechanisms that may involve synaptic actions or specific interactions within the EAS. Conclusion: Extracochlear EAS provides insights into its physiological implications, proposes a method for clinical application, and offers a potential avenue for improving hearing preservation and performance.
- 1 February 2022
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 142 (2) , 127-131
Optimal N-acetylcysteine concentration for intratympanic injection to prevent cisplatin-induced ototoxicity in guinea pigs
Cisplatin is a chemotherapy drug that can induce sensorineural hearing loss. At present, no otoprotective agent is approved for use.This study investigated the optimal concentration of intratympani... 背景:顺铂是一种可诱发感音神经性听力损失的化疗药物。目前还没有任何耳保护剂获准使用。目的:本研究调查了对于豚鼠模型, 防止顺铂诱发的耳毒性的鼓室内 N-乙酰半胱氨酸 (NAC) 的最佳浓度。材料和方法:豚鼠(n = 64)在腹腔注射顺铂 3 天之前, 用含有不同 NAC 浓度或盐水(对照)进行单次鼓室注射治疗。评估了听觉脑干反应的阈值变化。结果:腹腔内顺铂注射 4 周后, 与对照组相比, 只...
- 1 February 2022
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 142 (2) , 127-131
Optimal N-acetylcysteine concentration for intratympanic injection to prevent cisplatin-induced ototoxicity in guinea pigs
Cisplatin is a chemotherapy drug that can induce sensorineural hearing loss. At present, no otoprotective agent is approved for use.This study investigated the optimal concentration of intratympani... 背景:顺铂是一种可诱发感音神经性听力损失的化疗药物。目前还没有任何耳保护剂获准使用。目的:本研究调查了对于豚鼠模型, 防止顺铂诱发的耳毒性的鼓室内 N-乙酰半胱氨酸 (NAC) 的最佳浓度。材料和方法:豚鼠(n = 64)在腹腔注射顺铂 3 天之前, 用含有不同 NAC 浓度或盐水(对照)进行单次鼓室注射治疗。评估了听觉脑干反应的阈值变化。结果:腹腔内顺铂注射 4 周后, 与对照组相比, 只...
- Open Access
- 1 January 2021
- Published by Medknow in Tzu Chi Medical Journal
- Vol. 33 (1) , 42-48
Effects of different electrodes used in bone-guided extracochlear implants on electrical stimulation of auditory nerves in guinea pigs
Objective: Conventional cochlear implants provide patients who are deaf with hearing via electrical intracochlear stimulations. Stimulation electrodes are inserted into the cochlea through a cochleostomy or round window membrane (RWM) approach. However, these methods might induce cochlear ossificans and loss of residual hearing by damaging inner ear structures. To avoid an invasive electrode insertion, we developed a novel bone-guided extracochlear implant that stimulated the auditory nerves between the cochlear bones and the RWM to prevent cochlea damage. Power consumption plays an important role in wireless implantable electronic devices. Therefore, we aimed to investigate the effects of different electrodes on the stimulating threshold currents of the auditory nerve and the power consumption of bone-guided extracochlear implants using a commercial stimulator. Materials and Methods: Inert aurum (Au) electrodes were compared with biocompatible platinum (Pt) and iridium oxide (IrOx) electrodes in practical implantable applications. IrOx electrodes were used for their high-charge storage capacity, low impedance, and biocompatibility. The electrodes were fabricated via sputtering and were experimentally characterized with cyclic voltammetry and then examined using in vivo tests. Results: Based on electrical auditory brainstem responses, IrOx electrodes yielded lower acoustic nerve-stimulating threshold currents (132 μA) compared with Au electrodes (204 μA). IrOx electrodes also had a lower acoustic nerve stimulating threshold current (132 μA) compared with Pt electrodes (168 μA). Conclusion: As expected, IrOx electrodes were beneficial in the development of multielectrode bone-guided extracochlear implants, with the lowest acoustic nerve-stimulating threshold and current consumptions compared with Au and Pt electrodes.
- 1 January 2021
- Published by Medknow in Tzu Chi Medical Journal
- Vol. 33 (1) , 42-48
Open AccessEffects of different electrodes used in bone-guided extracochlear implants on electrical stimulation of auditory nerves in guinea pigs
Objective: Conventional cochlear implants provide patients who are deaf with hearing via electrical intracochlear stimulations. Stimulation electrodes are inserted into the cochlea through a cochleostomy or round window membrane (RWM) approach. However, these methods might induce cochlear ossificans and loss of residual hearing by damaging inner ear structures. To avoid an invasive electrode insertion, we developed a novel bone-guided extracochlear implant that stimulated the auditory nerves between the cochlear bones and the RWM to prevent cochlea damage. Power consumption plays an important role in wireless implantable electronic devices. Therefore, we aimed to investigate the effects of different electrodes on the stimulating threshold currents of the auditory nerve and the power consumption of bone-guided extracochlear implants using a commercial stimulator. Materials and Methods: Inert aurum (Au) electrodes were compared with biocompatible platinum (Pt) and iridium oxide (IrOx) electrodes in practical implantable applications. IrOx electrodes were used for their high-charge storage capacity, low impedance, and biocompatibility. The electrodes were fabricated via sputtering and were experimentally characterized with cyclic voltammetry and then examined using in vivo tests. Results: Based on electrical auditory brainstem responses, IrOx electrodes yielded lower acoustic nerve-stimulating threshold currents (132 μA) compared with Au electrodes (204 μA). IrOx electrodes also had a lower acoustic nerve stimulating threshold current (132 μA) compared with Pt electrodes (168 μA). Conclusion: As expected, IrOx electrodes were beneficial in the development of multielectrode bone-guided extracochlear implants, with the lowest acoustic nerve-stimulating threshold and current consumptions compared with Au and Pt electrodes.
- 25 February 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 66 (11) , 3156-3167
Design and In Vivo Verification of a CMOS Bone-Guided Cochlear Implant Microsystem
Objective: To develop and verify a CMOS bone-guided cochlear implant (BGCI) microsystem with electrodes placed on the bone surface of the cochlea and the outside of round window for treating high-frequency hearing loss. Methods: The BGCI microsystem consists of an external unit and an implanted unit. The external system-on-chip (SOC) is designed to process acoustic signals through an acquisition circuit and an acoustic DSP processor to generate stimulation patterns and commands that are transmitted to the implanted unit through a 13.56 MHz wireless power and bidirectional data telemetry. In the wireless power te-lemetry, a voltage doubler/tripler (2X/3X) active rectifier is used to enhance the power conversion efficiency and generate 2 V and 3 V output voltages. In the wireless data telemetry, phase-locked loop (PLL) based binary phase-shift keying (BPSK) and load-shift keying (LSK) modulators/demodulators are adopted for the down-link and uplink data through high-Q coils, respectively. The im-planted chip with 4-channel high-voltage-tolerant stimulator gen-erates biphasic stimulation currents up to 800 μA. Results: Electri-cal tests on the fabricated BGCI microsystem has been performed to verify the chip functions. The in-vivo animal tests in guinea pigs have shown the evoked third wave (Wave eIII) of electrically evoked auditory brainstem response (EABR) waveforms. It is ver-ified that auditory nerves can be successfully stimulated and acoustic hearing can be partially preserved. Conclusion and Significance: Different from traditional cochlear implants, the pro-posed BGCI microsystem is less invasive, preserves partially acoustic hearing, and provides an effective alternative to treating high-frequency hearing loss.
- 25 February 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Biomedical Engineering
- Vol. 66 (11) , 3156-3167
Design and In Vivo Verification of a CMOS Bone-Guided Cochlear Implant Microsystem
Objective: To develop and verify a CMOS bone-guided cochlear implant (BGCI) microsystem with electrodes placed on the bone surface of the cochlea and the outside of round window for treating high-frequency hearing loss. Methods: The BGCI microsystem consists of an external unit and an implanted unit. The external system-on-chip (SOC) is designed to process acoustic signals through an acquisition circuit and an acoustic DSP processor to generate stimulation patterns and commands that are transmitted to the implanted unit through a 13.56 MHz wireless power and bidirectional data telemetry. In the wireless power te-lemetry, a voltage doubler/tripler (2X/3X) active rectifier is used to enhance the power conversion efficiency and generate 2 V and 3 V output voltages. In the wireless data telemetry, phase-locked loop (PLL) based binary phase-shift keying (BPSK) and load-shift keying (LSK) modulators/demodulators are adopted for the down-link and uplink data through high-Q coils, respectively. The im-planted chip with 4-channel high-voltage-tolerant stimulator gen-erates biphasic stimulation currents up to 800 μA. Results: Electri-cal tests on the fabricated BGCI microsystem has been performed to verify the chip functions. The in-vivo animal tests in guinea pigs have shown the evoked third wave (Wave eIII) of electrically evoked auditory brainstem response (EABR) waveforms. It is ver-ified that auditory nerves can be successfully stimulated and acoustic hearing can be partially preserved. Conclusion and Significance: Different from traditional cochlear implants, the pro-posed BGCI microsystem is less invasive, preserves partially acoustic hearing, and provides an effective alternative to treating high-frequency hearing loss.
- Open Access
- 24 February 2015
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 34 (1) , 20
Methylation status of insulin-like growth factor-binding protein 7 concurs with the malignance of oral tongue cancer
Aberrant insulin-like growth factor-binding protein 7 (IGFBP-7) expression has been found in various cancers such as prostate, breast, and colon. IGFBP-7 induced the apoptosis of tumor and potentially predicted the clinical outcome in some cancers is further demonstrated. This study investigates the causes and underlying mechanisms of aberrant IGFBP-7 expression in unravelling head and neck squamous cell carcinoma (HNSCC). A total of 47 oral tongue cancer patient samples were primarily analyzed for the methylation status in 5′ region of IGFBP-7 by methylation-specific PCR (MS-PCR). Subsequently the invasion, overexpression, and knockdown of IGFBP-7 in the HNSCC A253 invasive subpopulation were employed to examine the effect of IGFBP-7. The epithelial–mesenchymal transition (EMT) marker genes and AKT/GSK3β/β-catenin signaling were further evaluated by Western blot for the understanding the role of aberrant IGFBP-7 expression and thereof putative mechanism. EMT expressed in the invasive subpopulation of HNSCC cell lines (A253 and RPMI 2650) was contemporary with the down-regulation of IGFBP-7. After treatment with 5-AZA-2′ deoxycytidine, the de-methylated CpG sites in the 5′ region of IGFBP-7 were observed and IGFBP-7 mRNA expression was also restored. Accordingly, re-expression IGFBP-7 in invasive subpopulation of A253 could induce the mesenchymal–epithelial transition (MET) and concurrently inhibited the cell invasion. Moreover, IGFBP-7 methylation status of 47 oral tongue tumors showed a positive correlation to invasive depth of the tumor, loco-regional recurrence, and cancer sequence. IGFBP-7 can alter EMT relative marker genes and suppress cell invasion in A253 cell through AKT/GSK3β/β-catenin signaling. The epigenetic control of IGFBP-7 in the invasion and metastasis of HNSCC was reported, suggesting that IGFBP-7 could be a prognostic factor for the probability of invasion and a therapeutic remedy.
- 24 February 2015
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 34 (1) , 20
Open AccessMethylation status of insulin-like growth factor-binding protein 7 concurs with the malignance of oral tongue cancer
Aberrant insulin-like growth factor-binding protein 7 (IGFBP-7) expression has been found in various cancers such as prostate, breast, and colon. IGFBP-7 induced the apoptosis of tumor and potentially predicted the clinical outcome in some cancers is further demonstrated. This study investigates the causes and underlying mechanisms of aberrant IGFBP-7 expression in unravelling head and neck squamous cell carcinoma (HNSCC). A total of 47 oral tongue cancer patient samples were primarily analyzed for the methylation status in 5′ region of IGFBP-7 by methylation-specific PCR (MS-PCR). Subsequently the invasion, overexpression, and knockdown of IGFBP-7 in the HNSCC A253 invasive subpopulation were employed to examine the effect of IGFBP-7. The epithelial–mesenchymal transition (EMT) marker genes and AKT/GSK3β/β-catenin signaling were further evaluated by Western blot for the understanding the role of aberrant IGFBP-7 expression and thereof putative mechanism. EMT expressed in the invasive subpopulation of HNSCC cell lines (A253 and RPMI 2650) was contemporary with the down-regulation of IGFBP-7. After treatment with 5-AZA-2′ deoxycytidine, the de-methylated CpG sites in the 5′ region of IGFBP-7 were observed and IGFBP-7 mRNA expression was also restored. Accordingly, re-expression IGFBP-7 in invasive subpopulation of A253 could induce the mesenchymal–epithelial transition (MET) and concurrently inhibited the cell invasion. Moreover, IGFBP-7 methylation status of 47 oral tongue tumors showed a positive correlation to invasive depth of the tumor, loco-regional recurrence, and cancer sequence. IGFBP-7 can alter EMT relative marker genes and suppress cell invasion in A253 cell through AKT/GSK3β/β-catenin signaling. The epigenetic control of IGFBP-7 in the invasion and metastasis of HNSCC was reported, suggesting that IGFBP-7 could be a prognostic factor for the probability of invasion and a therapeutic remedy.
- 18 July 2013
- Published by Elsevier in Applied Acoustics
- Vol. 74 (12) , 1511-1518
The development of a non-surgical direct drive hearing device with a wireless actuator coupled to the tympanic membrane
- 18 July 2013
- Published by Elsevier in Applied Acoustics
- Vol. 74 (12) , 1511-1518
The development of a non-surgical direct drive hearing device with a wireless actuator coupled to the tympanic membrane
- Open Access
- 21 November 2012
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 29 (3) , 133-139
Modeling sound transmission of human middle ear and its clinical applications using finite element analysis
We have developed a new finite element (FE) model of human right ear, including the accurate geometry of middle ear ossicles, external ear canal, tympanic cavity, and mastoid cavity. The FE model would be suitable to study the dynamic behaviors of pathological middle ear conditions, including changes of stapedial ligament stiffness, tensor tympani ligament (TTL), and tympanic membrane (TM) stiffness and thickness. Increasing stiffness of stapedial ligament has substantial effect on stapes footplate movement, especially at low frequencies, but less effect on umbo movement. Softer TTL will result in increasing umbo and stapes footplate displacement, especially at low frequencies ( f < 1000 Hz). When the TTL was detached, the vibration amplitude of umbo increased by 6 dB at 600 Hz and two peaks (300 and 600 Hz) were found in the vibration amplitude of stapes footplate. Increasing the stiffness of tensor tympani resulted in a slightly decreased umbo amplitude at very low frequencies ( f < 500 Hz) and significantly decreased displacement up to 12 dB at middle frequencies (1000 Hz < f < 4000 Hz). However, the amplitude change of stapes footplate is very sensitive to the TTL stiffness, especially at low frequency ( f < 1000 Hz). The increased stiffness of TM resulted in reduced umbo and stapes footplate displacement at frequencies 1500 Hz. As (TM) thickness was increased, the umbo displacement was reduced, especially at very low frequencies ( f < 600 Hz). Otherwise, the stapes displacement was reduced at all frequencies.
- 21 November 2012
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 29 (3) , 133-139
Open AccessModeling sound transmission of human middle ear and its clinical applications using finite element analysis
We have developed a new finite element (FE) model of human right ear, including the accurate geometry of middle ear ossicles, external ear canal, tympanic cavity, and mastoid cavity. The FE model would be suitable to study the dynamic behaviors of pathological middle ear conditions, including changes of stapedial ligament stiffness, tensor tympani ligament (TTL), and tympanic membrane (TM) stiffness and thickness. Increasing stiffness of stapedial ligament has substantial effect on stapes footplate movement, especially at low frequencies, but less effect on umbo movement. Softer TTL will result in increasing umbo and stapes footplate displacement, especially at low frequencies ( f < 1000 Hz). When the TTL was detached, the vibration amplitude of umbo increased by 6 dB at 600 Hz and two peaks (300 and 600 Hz) were found in the vibration amplitude of stapes footplate. Increasing the stiffness of tensor tympani resulted in a slightly decreased umbo amplitude at very low frequencies ( f < 500 Hz) and significantly decreased displacement up to 12 dB at middle frequencies (1000 Hz < f < 4000 Hz). However, the amplitude change of stapes footplate is very sensitive to the TTL stiffness, especially at low frequency ( f < 1000 Hz). The increased stiffness of TM resulted in reduced umbo and stapes footplate displacement at frequencies 1500 Hz. As (TM) thickness was increased, the umbo displacement was reduced, especially at very low frequencies ( f < 600 Hz). Otherwise, the stapes displacement was reduced at all frequencies.
- 29 June 2011
- Published by Elsevier in Applied Acoustics
- Vol. 72 (12) , 949-952
Polycarbonate nanoparticles spray coated on silicon substrate using micro-electromechanical-systems-based high-frequency ultrasonic nozzle
- 29 June 2011
- Published by Elsevier in Applied Acoustics
- Vol. 72 (12) , 949-952
Polycarbonate nanoparticles spray coated on silicon substrate using micro-electromechanical-systems-based high-frequency ultrasonic nozzle